Advertisement
Screener

Insys Therapeutics, Inc. Forms 3, 4 and 5: Preferred Stock

Insys Therapeutics, Inc. Forms 3, 4 and 5: Preferred Stock

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2013-05-07: Reporting owner Babich Michael L; Form 4; Security Convertible Preferred Stock; Transaction C Conversion of derivative security.
  • 2013-05-07: Reporting owner JOHN N KAPOOR TRUST DATED SEPTEMBER 20 1989 | KAPOOR JOHN N; Form 4; Security Convertible Preferred Stock; Transaction C Conversion of derivative security.
  • 2013-05-02: Reporting owner JOHN N KAPOOR TRUST DATED SEPTEMBER 20 1989 | KAPOOR JOHN N; Form 3; Security Convertible Preferred Stock; Transaction Holding.
  • 2013-05-02: Reporting owner Babich Michael L; Form 3; Security Convertible Preferred Stock; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2013-05-07Babich Michael L
Director, Officer (President and CEO)
4Convertible Preferred Stock
Derivative · Direct
C Conversion of derivative security−10,899
0 owned after
$0.002013-05-08
2013-05-07JOHN N KAPOOR TRUST DATED SEPTEMBER 20 1989 | KAPOOR JOHN N
10% Owner | Director, 10% Owner
4Convertible Preferred Stock
Derivative · Indirect · By Trust
C Conversion of derivative security−6,797,388
0 owned after
$0.002013-05-08
2013-05-02
holding as of filing
JOHN N KAPOOR TRUST DATED SEPTEMBER 20 1989 | KAPOOR JOHN N
10% Owner | Director, 10% Owner
3Convertible Preferred Stock
Derivative · Indirect · (m)
Holdingno price filed2013-05-02
2013-05-02
holding as of filing
Babich Michael L
Director, Officer (President and CEO)
3Convertible Preferred Stock
Derivative · Direct
Holdingno price filed2013-05-02